Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated (NYSE: AFL) is a Fortune 500 insurer in the direct life and supplemental health insurance space, with major operations in the United States and Japan. The AFL news feed on Stock Titan brings together company-issued updates and market-moving announcements that reflect how Aflac manages its insurance business, capital, partnerships and community initiatives.
Recent Aflac news has covered a range of topics, including quarterly and annual earnings releases, dividend declarations and conference call schedules where management discusses financial results. These items provide insight into segment performance for Aflac U.S. and Aflac Japan, trends in net earned premiums and adjusted earnings, and the company’s approach to capital deployment through dividends and share repurchases.
News stories also highlight Aflac’s strategic partnerships and product-related initiatives. Examples include collaborations to integrate Aflac’s supplemental health products with benefits technology platforms and administrative partners, particularly in the public sector market and employer benefits space. Such announcements illustrate how Aflac connects its supplemental health offerings with employer-sponsored benefits and consumer-directed health care administration.
Aflac’s communications frequently emphasize its role in workplace benefits trends through the Aflac WorkForces Report, which examines employee stress, burnout, financial fragility and the perceived value of supplemental insurance. Other articles focus on the company’s philanthropic efforts, such as support for the Aflac Childhood Cancer Foundation, the My Special Aflac Duck® program and the “Beyond Words” children’s book, all aimed at assisting children and families facing cancer and blood disorders.
Investors and observers following AFL news can use this page to monitor earnings announcements, dividend decisions, risk disclosures, benefits-related research and community initiatives that shape Aflac’s profile as a supplemental health and life insurer. Bookmark this feed to review new press releases and regulatory-related communications as they are issued by the company.
Aflac Incorporated reported third quarter 2024 results with total revenues of $2.9 billion, a decline from $5.0 billion in Q3 2023. The company posted net losses of $93 million ($0.17 per diluted share) compared to earnings of $1.6 billion ($2.64 per diluted share) a year ago, primarily due to foreign exchange-related losses from yen strengthening by 12.9%.
Net investment losses were $1.4 billion, driven by losses on derivatives and foreign currency activities. However, adjusted earnings increased by 10.6% to $1.2 billion, with adjusted EPS rising 17.4% to $2.16.
Shareholders' equity grew to $24.8 billion ($44.60 per share) from $22.7 billion ($38.63 per share) a year ago. Aflac declared a fourth quarter dividend of $0.50 per share and repurchased $500 million in common shares.
In Japan, net earned premiums in yen fell 10.5%, while in the U.S., net earned premiums increased 2.8%. The company emphasized continued focus on profitable growth in both markets.
Aflac has won the 2024 CSO Award for its 'Quackcess Granted' Passkey Authentication Initiative, powered by Transmit Security. The project implemented passkey authentication as a secure alternative to traditional passwords, achieving a 96% login success rate and 32% adoption rate among policyholders, surpassing the initial 10% target. Over 265,000 Aflac policyholders have enrolled in the program, with no reported login failures and minimal technical support needs. The initiative, built on FIDO standards, allows customers to sync biometric credentials across devices through cloud technology, eliminating passwords and outdated multi-factor authentication methods.
According to the 2024 Aflac Wellness Matters Survey, 3 in 5 Americans have avoided recommended health screenings. The survey reveals that cancer patients were more likely to have avoided screenings, though 56% of diagnoses came from routine exams. Aflac employees shared personal experiences highlighting the importance of regular screenings, particularly regarding skin cancer detection. Multiple cases demonstrated how routine check-ups led to early detection and successful treatment of melanoma and other skin cancers, emphasizing the critical role of preventive care and regular wellness appointments.
In September, My Special Aflac Duck® visited New York City, bringing joy to pediatric cancer and sickle cell patients at The Children's Hospital at Montefiore Einstein. Aflac partnered with Sunrise Day Camp to provide fun activities for children and families. My Special Aflac Duck is a social robot that helps kids prepare for medical procedures and communicate their feelings.
A recent study showed reduced distress, nausea, pain, and anxiety in children who received the duck. Since 2018, Aflac has distributed over 32,000 ducks free of charge to patients aged 3 and up. This program is part of Aflac's $184 million contribution to pediatric cancer and blood disorder research and programs. Health care providers and families can order the duck for free at MySpecialAflacDuck.com.
Aflac's philanthropic mission focuses on supporting childhood cancer and sickle cell patients. Over nearly three decades, the company has donated more than $184 million and delivered over 32,000 My Special Aflac Ducks to pediatric patients. The annual 'Bridge to Brighter' initiative, launched in September 2023, aims to raise awareness about these illnesses.
This year's campaign includes news anchors wearing burgundy and gold ribbons, celebrity partnerships, and the first official My Special Aflac Duck delivery event in New York City. The initiative also provides resources for supporters, including tips on offering help, donation options, and pre-made social media posts. Aflac encourages public participation in building a bridge to a brighter future for those facing cancer and blood disorders through their website Aflac.com/BridgeToBrighter.
Aflac Incorporated (NYSE: AFL) has announced the release of its third quarter 2024 financial results after market close on October 30, 2024. The company will make available its quarterly earnings release, financial supplement, and a financial update video from CFO Max Brodén on its Investor Relations website.
Additionally, Aflac will host a webcast conference call on October 31, 2024, at 8:00 a.m. (ET). During this call, Chairman, CEO, and President Daniel P. Amos, along with CFO Max Brodén, will discuss the quarterly results and outlook. They will also answer questions with other executive management members from the U.S. and Japan.
Interested parties can register for the webcast at investors.aflac.com five to seven minutes before the scheduled start time.
Aflac and Prudential Financial conducted dual studies on the impact of paid leave in the workplace, revealing significant stress on employees covering for absent coworkers. Key findings include:
- 73% of workers experienced stress and anxiety while covering for a coworker on leave
- 42% experienced burnout when covering for leaves extending beyond 9 weeks
- 48% of employers have seen an increase in employee leaves in the past 12 months
- 94% of employers report taking action to support employees covering for coworkers, but only 74% of employees acknowledge this
The studies highlight the need for effective communication and recognition to support employees maintaining business continuity during coworkers' absences. Employers are encouraged to evaluate their work environment and implement strategies to preserve employee well-being while managing increased leaves.
Aflac is raising awareness for National Childhood Cancer and Sickle Cell Disease Awareness Month this September. The company offers tips on how to support affected families, including providing meals, spending time together, sending supportive messages, helping with tasks, assisting with caregiving, and offering comfort items.
Aflac has donated over $184 million since 1995 to support children with cancer and blood disorders. They created My Special Aflac Duck, a free robotic companion for children with cancer or sickle cell disease, clinically proven to reduce stress. To date, over 32,000 ducks have been distributed.
The company encourages people to visit Aflac.com/BridgeToBrighter for inspirational stories, comfort tips, and information on requesting a duck for eligible children.
Aflac, a leading U.S. health supplemental insurance provider, is renewing its Bridge to Brighter program for Childhood Cancer and Sickle Cell Awareness Month in September. The company has raised nearly $184 million since 1995 for pediatric cancer and blood disorder initiatives, including support for the Aflac Cancer and Blood Disorders Center at Children's Hospital of Atlanta. Aflac has launched a dedicated webpage offering resources such as:
- A broadcast news video
- Information about the My Special Aflac Duck robotic companion
- Messages from sports coaches
- Donation opportunities
- Digital toolkit and social media resources
Additionally, the Aflac Childhood Cancer Foundation is providing $15,000 in grants to support Child Life Specialist programs nationwide.
Aflac Incorporated, a leading health supplemental insurance provider in the U.S., has donated 40 My Special Aflac Ducks to pediatric cancer and sickle cell patients at Children's Hospital at Montefiore (CHAM) in The Bronx. This marks Aflac's first delivery in New York, bringing the total number of ducks distributed since 2018 to over 31,000. My Special Aflac Duck is a social robot designed to help children prepare for medical procedures, communicate feelings, and practice distraction techniques.
A recent three-year study showed that the duck helps reduce distress, nausea, pain, and treatment anxiety in children. The program is part of Aflac's broader commitment to pediatric cancer and blood disorder research, with over $184 million donated to date. Health care providers and families can order My Special Aflac Duck free of charge for eligible children at MySpecialAflacDuck.com.
FAQ
What is the current stock price of Aflac (AFL)?
What is the market cap of Aflac (AFL)?
